Почетна › Difuzni veliki B-ćelijski limfom › Њујорк › New York City
Kliničke studije za Difuzni veliki B-ćelijski limfom u gradu New York City, NY
20 studija za Difuzni veliki B-ćelijski limfom traži učesnike na lokacijama u gradu New York City i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
Тражи се учесникФаза 3
- Icahn School of Medicine at Mount Sinai ( Site 0164), New York
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Тражи се учесникФаза 2
- Laura and Isaac Perlmutter Cancer Center at NYU Langone ( Site 0108), New York
Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
Тражи се учесникФаза 1
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Тражи се учесникФаза 1
- New York University (NYU) Clinical Cancer Center, New York
- Weill Cornell Medicine, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
Тражи се учесникФаза 1
- Columbia University, New York
A Study of Glofitamab-based Treatment in People With Diffuse Large B-cell Lymphoma
Тражи се учесникФаза 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Тражи се учесникФаза 1/2
- Memorial Sloan Kettering Cancer Center ( Site 1010), New York
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Тражи се учесникФаза 2
- Columbia University Irving Medical Center and New York-Presbyterian Hospital, New York
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
Тражи се учесникФаза 2
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Low-Dose TBI Plus CAR T-Cell Therapy for Relapsed/Refractory DLBCL and Multiple Myeloma
Тражи се учесникФаза 1
- Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Тражи се учесникФаза 2
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- NYP/Weill Cornell Medical Center, New York
Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
Тражи се учесник
- Memorial Sloan Kettering Cancer Center (All protocol activities), New York
- NEW YORK PRESBYTERIAN HOSPITAL (Data Collection Only), New York
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
Тражи се учесникФаза 1
- Memorial Sloan Kettering Cancer Center, New York
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Тражи се учесникФаза 1/2
- Columbia University Medical Center, New York
- Weill Cornell Medical College Newyork Presbyterian Hospital, New York
- Memorial Sloan Kettering Cancer Center Mskcc, New York
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Тражи се учесникФаза 1/2
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
DALY II USA/ MB-CART2019.1 for DLBCL
Тражи се учесникФаза 2
- Memorial Sloan Kettering Cancer Center, New York
Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
Тражи се учесникФаза 1
- Memorial Sloan Kettering Cancer Center, New York
ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL
Тражи се учесник
- Columbia University, New York
A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma
Тражи се учесникФаза 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy
Тражи се учесникФаза 2
- Memorial Sloan Kettering Cancer Center, New York
Studije za Difuzni veliki B-ćelijski limfom u drugim gradovima
- Baldwin Park, CA19 студија
- Los Angeles, CA18 студија
- Houston, TX18 студија
- Chicago, IL18 студија
- Milwaukee, WI17 студија
- Nashville, TN17 студија
- Boston, MA17 студија
- Philadelphia, PA15 студија
- Durham, NC15 студија
- Portland, OR15 студија
- Cleveland, OH13 студија
- Seattle, WA13 студија
Ostale studije u gradu New York City
- Рак дојке144 студија
- Немалоклетни карцином плућа123 студија
- Рак (све врсте)105 студија
- Рак простате101 студија
- Метастатски карцином93 студија
- Колоректални карцином86 студија
- Рак јајника75 студија
- Рак плућа60 студија
- Многи мијелом59 студија
- Рак панкреаса57 студија
- Карцином ендометријума54 студија
- Akutna mijeloidna leukemija51 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.